Long-term kidney regraft survival from deceased donors: Risk factors and outcomes in a single center

Transplantation

Volumn 86, Issue 8, 2008, Pages 1084-1089

  Arnol, Miha ^a,b   Prather, Jonathan C ^a   Mittalhenkle, Anuja ^a   Barry, John M ^a   Norman, Douglas J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Graft survival; Kidney retransplantation; Risk factors

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CADAVER KIDNEY; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; AGE; COMPARATIVE STUDY; DIABETES MELLITUS; DONOR; GRAFT REJECTION; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; REOPERATION; TIME;

ADULT; AGE FACTORS; DIABETES COMPLICATIONS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE DONORS;

EID: 55949089941     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318187ba5c     Document Type: Article

References (24)

1. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural historyof chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
2. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2002: 1.
3. 2005 OPTN/SRTR Annual report 1995-2004. HHS/HRSA/HSB/DOT; UNOS; Arbor research collaborative for health.
4. Ojo AO, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analysis from the United States renal data system. Transplantation 1998; 66: 1651.
5. Rao PS, Schaubel DE, Jia X, et al. Survivalon dialysis post-kidney transplant failure: Results from the scientific registry of transplant recipients. Am J Kidney Dis 2007; 49: 294.
6. Rao PS, Schaubel DE, Wei G, et al. Evaluating the survival benefit of kidney retransplantation. Transplantation 2006; 82: 669.
7. Scornik JC. Detectionofalloantibodiesbyflow cytometry: Relevance to clinical transplantation. Cytometry 1995; 22: 259.
8. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transpl 2002; 335.
9. Abouljoud MS, Deierhoi MH, Hudson SL, et al. Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy. Transplantation 1995; 60: 138.
10. Miles CD, Schaubel DE, Jia X, et al. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant 2007; 7: 1140.
11. Nelson PW, Eschliman P, Shield CF, et al. Improved graft survival in cadaveric renal retransplantation by flow crossmatching. Transplantation 1996; 131: 599.
12. Golconda MS, deMatos AM, Prather J, et al. Renal transplantation at Oregon Health and Sciences University: Recent results and protocols. Clin Transpl 2003; 149.
13. Kaplan B,Meier-Kriesche HU. Death after graft loss: An important late study endpointinkidney transplantation. Am J Transplant 2002;2:970.
14. Howard RJ, Reed AI, Van Der Werf WJ, et al. What happens to renal transplant recipients who loose their grafts? Am J Kidney Dis 2001; 38: 31.
15. Stratta RJ, Oh CS, Sollinger HW, et al. Kidney retransplantation in the cyclosporine era. Transplantation 1988; 45: 40.
16. Soran A, Basar H, Shapiro R, et al. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc 2000; 32: 663.
17. El-Agroudy AE, Wafa EW, Bakr MA, et al. Living-donor kidney retransplantation: Risk factors and outcome. BJU Int 2004; 94: 369.
18. Magee JC, Barr ML, Basadonna GP, et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007; 7: 1424.
19. RigdenS, MehlsO, GellertR. Factors influencing second renal allograft survival. Nephrol Dial Transplant 1999; 14: 566.
20. Christiaans MHL, Overhof R, ten Haaft A, et al. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicityinim-munologically well-documented renal allograft recipients. Transplantation 1996; 62: 1341.
21. Meier-Kriesche HU, Kaplan B.Waiting timeondialysisasthe strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis. Transplantation 2002; 74: 1377.
22. Wanner C,Zimmermann J, Quaschning T, et al. Inflammation, dyslip-idemia and vascular risk factors in hemodialysis patients. Kidney Int Suppl 1997; 62: S53.
23. Kaufmann P, Smolle KH, Horina JH, et al. Impact of long-term hemo-dialysis on nutritional status in patients with end-stage renal failure. Clin Investig 1994; 72: 754.
24. Descamps-Latscha B, Herbelin A, Nguyen AT, et al. Immune system dysregulation in uremia. Semin Nephrol 1994; 14: 253.